Vimarsana
Biggest News Aggregation in the World

Page 8 - Solara Active Pharma Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solara Active Pharma Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solara Active Pharma Sciences Today - Breaking & Trending Today

HRKatha's Automation.NXT Conference puts the spotlight on HR's Role in Digitalisation - Vimarsana News

HRKatha's Automation.NXT Conference puts the spotlight on HR's Role in Digitalisation

New Delhi [India], October 3 (ANI/NewsVoir): Holiday Inn, Aerocity was the venue for interesting discussions on automation and HR's role in the digital-transformation process on September 29, 2022. The conference, aptly christened Automation.NXT - organised by HRKatha, and powered by Tata Steel Industrial Consulting, with UKG as workforce management partner, Onsurity as SME healthcare partner, NHRDN as community partner, and OpenOffers as lanyard partner - was the reason why so many great minds from the HR fraternity came together to share their valuable experiences and lessons learnt from...

Global Ibuprofen API Market Set To Reach USD 772.4 Million By 2030, Thriving With A CAGR Of 3% - Vimarsana News

Global Ibuprofen API Market Set To Reach USD 772.4 Million By 2030, Thriving With A CAGR Of 3%

/PRNewswire/ -- According to a recent market study published by Growth Market Reports, titled, "Global Ibuprofen API Market" by Applications (Arthritis,...

Ibuprofen API Market Analysis, Size, Applications Share, Trends & Forecast To 2029 - Vimarsana News

Ibuprofen API Market Analysis, Size, Applications Share, Trends & Forecast To 2029

The global Ibuprofen API Market surpassed US$ 626.2 Mn in 2022 and is anticipated to increase at a CAGR of 3% to reach US$ 772.2 Mn by 2029. as per the findings of a new Future Market Insights (FMI) study. The primary factors for the growth of the Ibuprofen API market include continuous demand for low-cost non-stero...

Up 525% return! These 16 stocks made big money for investors in the first half of 2022 - Vimarsana News

Up 525% return! These 16 stocks made big money for investors in the first half of 2022

Following the heavy selling in the equity markets, the market value of BSE-listed firms retreated to Rs 245 lakh crore on June 28, 2022 from Rs 266 lakh crore on December 31 last year. 

2022: Best And Worst Performing Stocks So Far - Vimarsana News

2022: Best And Worst Performing Stocks So Far

Traders and investors alike have found it challenging to navigate the market amid the ongoing volatility

Source: ndtv.com